Literature DB >> 8750187

The clinical significance of malfunction of the CD44 locus in malignancy.

D Tarin1, J Bolodeoku, S J Hatfill, T Sugino, A C Woodman, K Yoshida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8750187     DOI： 10.1007/bf01052624

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  54 in total

1.  Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.

Authors:  M Culty; M Shizari; E W Thompson; C B Underhill
Journal:  J Cell Physiol       Date:  1994-08       Impact factor: 6.384

2.  Demonstration of CD44 gene expression in cells from fine needle aspirates of breast lesions by the polymerase chain reaction.

Authors:  J Bolodeoku; K Yoshida; P Yeomans; C A Wells; D Tarin
Journal:  Clin Mol Pathol       Date:  1995-12

3.  Expression of CD44 is repressed in neuroblastoma cells.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

4.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

Authors:  K K Tanabe; L M Ellis; H Saya
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

5.  Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.

Authors:  A Chaudhry; A Gobl; B Eriksson; B Skogseid; K Oberg
Journal:  Cancer Res       Date:  1994-02-15       Impact factor: 12.701

6.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

7.  Expression of CD44 in prostate cancer cells.

Authors:  A Y Liu
Journal:  Cancer Lett       Date:  1994-01-15       Impact factor: 8.679

8.  Participation in normal immune responses of a metastasis-inducing splice variant of CD44.

Authors:  R Arch; K Wirth; M Hofmann; H Ponta; S Matzku; P Herrlich; M Zöller
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

9.  Distinct effects of two CD44 isoforms on tumor growth in vivo.

Authors:  M S Sy; Y J Guo; I Stamenkovic
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.

Authors:  M Salmi; K Grön-Virta; P Sointu; R Grenman; H Kalimo; S Jalkanen
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539
View more
  5 in total

1.  Endothelial adhesion of synchronized gastric tumor cells changes during cell cycle transit and correlates with the expression level of CD44 splice variants.

Authors:  Anton Oertl; Jens Castein; Tobias Engl; Wolf-Dietrich Beecken; Dietger Jonas; Richard Melamed; Roman A Blaheta
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

2.  Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.

Authors:  A C Woodman; M Sugiyama; K Yoshida; T Sugino; A Borgya; S Goodison; Y Matsumura; D Tarin
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Progressive loss of CD44 gene expression in invasive bladder cancer.

Authors:  T Sugino; H Gorham; K Yoshida; J Bolodeoku; V Nargund; D Cranston; S Goodison; D Tarin
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Differential expression of CD44 variants among meningioma subtypes.

Authors:  S O Suzuki; T Iwaki; T Kitamoto; M Mizoguchi; M Fukui; J Tateishi
Journal:  Clin Mol Pathol       Date:  1996-06

5.  Distribution of CD44 messenger RNA in archival paraffin wax embedded tumours and normal tissues viewed by in situ hybridisation.

Authors:  H Gorham; T Sugino; J Bolodeoku; K Yoshida; S Goodison; D Tarin
Journal:  Clin Mol Pathol       Date:  1996-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.